全文获取类型
收费全文 | 16511篇 |
免费 | 997篇 |
国内免费 | 653篇 |
专业分类
耳鼻咽喉 | 175篇 |
儿科学 | 574篇 |
妇产科学 | 298篇 |
基础医学 | 1242篇 |
口腔科学 | 148篇 |
临床医学 | 1504篇 |
内科学 | 4962篇 |
皮肤病学 | 190篇 |
神经病学 | 869篇 |
特种医学 | 260篇 |
外科学 | 842篇 |
综合类 | 2535篇 |
一般理论 | 2篇 |
预防医学 | 2395篇 |
眼科学 | 310篇 |
药学 | 625篇 |
4篇 | |
中国医学 | 928篇 |
肿瘤学 | 298篇 |
出版年
2024年 | 38篇 |
2023年 | 347篇 |
2022年 | 799篇 |
2021年 | 963篇 |
2020年 | 937篇 |
2019年 | 728篇 |
2018年 | 681篇 |
2017年 | 602篇 |
2016年 | 662篇 |
2015年 | 701篇 |
2014年 | 1264篇 |
2013年 | 1375篇 |
2012年 | 968篇 |
2011年 | 1121篇 |
2010年 | 932篇 |
2009年 | 795篇 |
2008年 | 725篇 |
2007年 | 639篇 |
2006年 | 496篇 |
2005年 | 448篇 |
2004年 | 367篇 |
2003年 | 404篇 |
2002年 | 283篇 |
2001年 | 246篇 |
2000年 | 168篇 |
1999年 | 142篇 |
1998年 | 110篇 |
1997年 | 130篇 |
1996年 | 91篇 |
1995年 | 73篇 |
1994年 | 76篇 |
1993年 | 47篇 |
1992年 | 43篇 |
1991年 | 45篇 |
1990年 | 35篇 |
1989年 | 24篇 |
1987年 | 33篇 |
1985年 | 52篇 |
1984年 | 62篇 |
1983年 | 39篇 |
1982年 | 38篇 |
1981年 | 44篇 |
1980年 | 60篇 |
1979年 | 48篇 |
1978年 | 31篇 |
1976年 | 28篇 |
1974年 | 23篇 |
1973年 | 33篇 |
1972年 | 25篇 |
1971年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
51.
目的 探讨神经系统疾病患者血小板参数的变化。方法 测定神经系统疾病患者血小板数(PLT)和平均血小板体积(MPV),并与对照组作比较。结果 与对照组比较,脑梗死、椎-基底动脉供血不足患者PLT明显减少,MPV明显增大;脑出血组MPV、PLT均减少。结论 血小板参数的变化对神经系统疾病的诊断、预防和治疗有重要的参考价值。 相似文献
52.
53.
Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis 总被引:4,自引:0,他引:4
Summary Levels of soluble IL-2 receptors, IL-6, soluble CD23, soluble CD14 and ECP (eosinophilic cationic protein) were measured as markers of T-cell, B-cell, monocyte and eosinophilic leucocyte activation in 26 patients with atopic dermatitis (AD) on admission to (A) and at discharge from (D) the Department of Dermatology in Zurich. The serum levels of sIL-2R, IL-6, sCD23, sCD14 and ECP were significantly elevated in AD patients in comparison with the normal values of healthy donors. A significant decrease in sIL-2R (p=0.0093) and in sCD14 (p=0.0134) levels was demonstrated between A and D, correlating with the improvement in the skin intensity score (SIS). In addition, a significant correlation of the sCD14 levels and the SIS at A was demonstrated (p=0.0415). These results also incriminate monocytes in the pathogenesis of AD, indicating that, besides sIL-2R and ECP, SCD14 could also be a possible marker for the disease activity. 相似文献
54.
目的 提高对母亲苯丙酮尿症(MPKU)后代脑MRI表现的认识。资料与方法 报告2例生化及临床检查证实为MPKU双胞胎的.MRI改变,并复习文献。结果 文中2例表现与文献报道不一致.与苯丙酮尿症患儿的表现相似。常规T2WI及FLAIR均显示室周白质、侧脑室三角区、半卵圆中心条片状高信号。弥散加权成像(DWI)除更清楚地显示上述改变外,尚显示双侧内囊后肢及胼胝体压部信号增高。结论 常规T2WI及FIJAIR上可显示MPKU后代脑白质异常,DWI可提供更多诊断依据。 相似文献
55.
目的络合碘预防阑尾切除术后切口感染。方法0.05%络合碘冲洗切口65例。结果络合碘冲洗的化脓、坏疽或穿孔性阑尾炎切口无感染,与传统组感染率9.1%(6/66)比较p〈0.05(x^2=4.266)。结论0.05%络合碘冲洗切口是预防阑尾切除术后切口感染的有效方法。 相似文献
56.
Kallol Ray Chaudhuri Pablo Martinez-Martin Anthony H V Schapira Fabrizio Stocchi Kapil Sethi Per Odin Richard G Brown William Koller Paolo Barone Graeme MacPhee Linda Kelly Martin Rabey Doug MacMahon Sue Thomas William Ondo David Rye Alison Forbes Susanne Tluk Vandana Dhawan Annette Bowron Adrian J Williams Charles W Olanow 《Movement disorders》2006,21(7):916-923
Nonmotor symptoms (NMS) of Parkinson's disease (PD) are not well recognized in clinical practice, either in primary or in secondary care, and are frequently missed during routine consultations. There is no single instrument (questionnaire or scale) that enables a comprehensive assessment of the range of NMS in PD both for the identification of problems and for the measurement of outcome. Against this background, a multidisciplinary group of experts, including patient group representatives, has developed an NMS screening questionnaire comprising 30 items. This instrument does not provide an overall score of disability and is not a graded or rating instrument. Instead, it is a screening tool designed to draw attention to the presence of NMS and initiate further investigation. In this article, we present the results from an international pilot study assessing feasibility, validity, and acceptability of a nonmotor questionnaire (NMSQuest). Data from 123 PD patients and 96 controls were analyzed. NMS were highly significantly more prevalent in PD compared to controls (PD NMS, median = 9.0, mean = 9.5 vs. control NMS, median = 5.5, mean = 4.0; Mann-Whitney, Kruskal-Wallis, and t test, P < 0.0001), with PD patients reporting at least 10 different NMS on average per patient. In PD, NMS were highly significantly more prevalent across all disease stages and the number of symptoms correlated significantly with advancing disease and duration of disease. Furthermore, frequently, problems such as diplopia, dribbling, apathy, blues, taste and smell problems were never previously disclosed to the health professionals. 相似文献
57.
糖尿病肾病临床研究述评 总被引:54,自引:0,他引:54
本文从中医病名、病因病机、诊断标准、临床分期、疗效评定、辨证论治、临床科研七个方面对糖尿病肾病的研究进行了述评。指出:糖尿病肾病的中医病名、诊断、分期及疗效评定标准亟待统一;立足于临床实际,参考现代医学有关认识,应用DME方法,开展糖尿病肾病临床和实验研究,深入探讨其病因病机和证治规律,在中医基本理论指导下,大胆创新,是提高临床疗效的关键;分期辨证论治较为符合疾病的发展规律,便于寻找防治糖尿病肾病的有效方法。 相似文献
58.
本文报告13例嗜肺军团菌肺炎。其中Lp1型6例;Lp6型6例;Lp12型1例。Lp12型国内尚未见文献报告。对临床表现,实验室检查,X线胸部征象,治疗和预后进行分析。并将部分资料与美国洛杉矶Wadsworth医疗中心统计资料分析对比,以探讨国人嗜肺军团菌肺炎临床特征。 相似文献
59.
作者于1987年2月16日~1988年2月15日在四川五个点211 639人群中监测急性病毒性肝炎。其发病率为167.74/10万,其中甲型肝炎占24.51%;乙型肝炎占38.31%;非甲非乙型肝炎占24.51%,EB病毒和巨细胞病毒所致肝炎各占3.38%;混合感染占5.92%。病毒性肝炎中有14.93%重叠感染。发病高峰在春季。发病率,男:女=1.75:1。甲型肝炎20岁以下年龄组、乙型肝炎20~39岁年龄组的发病率明显高于其他年龄组,非甲非乙型较分散,5~19岁相对多一些,其他型别年龄组间无明显差异。355例急性病毒性肝炎患者中43.9%有接触史,36.6%有注射史。 相似文献
60.
A model was developed which estimates the costs of osteoporosis risk evaluation and treatment, and the resulting savings in terms of reduced fracture frequency, for the adult female population of the United States. In the absence of treatment, the model predicts 1.44 million fractures will occur annually from non-violent causes. Treatment of all women beginning at age 50 with an agent that slows bone loss by 50% would reduce the number of these fractures by 0.59 million. Selective treatment of the 47% of women at the greatest fracture risk would reduce the number of fractures by 0.45 million, but would only cost 47% as much as treating all women. Additional data are required before the model can be used to evaluate specific treatment regimens. However, it appears that selective treatment of those at highest risk would yield the greatest benefit to cost ratio, if only benefits related to reduced fracture frequency are considered. 相似文献